# CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD)

> **NCT02499601** · NA · UNKNOWN · sponsor: **CorAssist Cadiovascular Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Diastolic Heart Failure
- Diastolic Dysfunction

## Interventions

- **DEVICE:** CORolla™ TAA device

## Key facts

- **NCT ID:** NCT02499601
- **Lead sponsor:** CorAssist Cadiovascular Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2021-09
- **Final completion:** 2024-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02499601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02499601, "CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02499601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*